Connect with us


China Grants Patent To New COVID-19 Medicine

Avatar of Arsi Mughal



China Grants Patent To New COVID-19 Medicine

(CTN News) – China has granted a patent on a new COVID-19 medicine, which is claimed to be able to dramatically slow the copying of the coronavirus that is causing the current pandemic.

Cepharanthine (CEP) is an extract of Stephania and has previously been used to treat other diseases. During the global outbreak of COVID-19, scientists found that the drug could also be used to treat the new disease.

“If there are 15,393 viruses without CEP, there will be only one with just 10 micromole of CEP per liter,” Tong Yigang, the first patentee, said. Therefore, a tiny amount of CEP can prevent the virus from spreading.”

According to Tong, CEP is one of the best inhibitors of COVID-19 known to humans.

When the outbreak started in January 2020, Tong’s team began searching for the best drug, and they published their findings about CEP in March 2020, a world first.

Similar findings were also published later by researchers from many other countries.

However, it might take longer for the drug to reach the market.

According to an account on, owned by Fan Huahao, the second patentee, the drug is an old one used for a new condition. “Companies are cautious, and we need government assistance.”

Fan said the team has limited resources to launch clinical trials.

The Canadian drug company PharmaDrug has been given permission by the FDA to conduct a clinical trial, which is expected to begin in the second half of 2022.

Related CTN News:

SIDS Study Shows The Risks Of Science Hype, But More Work To Come, Expert Says
Tesla Sales in China Drop by 98% Due To Strict COVID-19 Lockdown
Hepatitis Cases in Children Under 13 Raising Serious Flags

Arsi Mughal is a staff writer at CTN News, delivering insightful and engaging content on a wide range of topics. With a knack for clear and concise writing, he crafts articles that resonate with readers. Arsi's pieces are well-researched, informative, and presented in a straightforward manner, making complex subjects accessible to a broad audience. His writing style strikes the perfect balance between professionalism and casual approachability, ensuring an enjoyable reading experience.

Continue Reading

CTN News App

CTN News App

Recent News


compras monedas fc 24

Advertise here

Volunteering at Soi Dog

Find a Job

Jooble jobs

Free ibomma Movies